XmAb23104

XmAb23104 · Xencor, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XmAb23104, covering 2024-07-05 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XmAb23104 in People With Sarcoma [Phase 2]